Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
January 1, 2017
S-1 plus sorafenib for the treatment of advanced hepatocellular carcinoma
Wukui Huang, Lina You, Dengyao Liu, et al.
The American Journal of Gastroenterology
|
November 19, 2014
Combination therapy with sorafenib and radiofrequency ablation for BCLC Stage 0-B1 hepatocellular carcinoma: a multicenter retrospective cohort study
Xiaobin Feng, Ruocai Xu, Xilin Du, et al.
Liver Cancer
|
July 11, 2020
Exploratory Analysis to Identify Candidates Benefitting from Combination Therapy of Transarterial Chemoembolization and Sorafenib for First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Observational Study
Zhexuan Wang, Enxin Wang, Wei Bai, et al.
Liver Cancer
|
August 18, 2022
Lenvatinib with or without Concurrent Drug-Eluting Beads Transarterial Chemoembolization in Patients with Unresectable, Advanced Hepatocellular Carcinoma: A Real-World, Multicenter, Retrospective Study
Dongdong Xia, Wei Bai, Enxin Wang, et al.
European Radiology
|
April 6, 2022
Optimal time point of response assessment for predicting survival is associated with tumor burden in hepatocellular carcinoma receiving repeated transarterial chemoembolization
Dongdong Xia, Qiuhe Wang, Wei Bai, et al.
Journal of Hepatology
|
January 21, 2019
Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational study
Qiuhe Wang, Dongdong Xia, Wei Bai, et al.
JHEP Reports : Innovation in Hepatology
|
January 6, 2025
Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study<sup>☆</sup>
Dongdong Xia, Wei Bai, Qiuhe Wang, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
January 1, 2017
S-1 plus sorafenib for the treatment of advanced hepatocellular carcinoma
Wukui Huang, Lina You, Dengyao Liu, et al.
The American Journal of Gastroenterology
|
November 19, 2014
Combination therapy with sorafenib and radiofrequency ablation for BCLC Stage 0-B1 hepatocellular carcinoma: a multicenter retrospective cohort study
Xiaobin Feng, Ruocai Xu, Xilin Du, et al.
Liver Cancer
|
July 11, 2020
Exploratory Analysis to Identify Candidates Benefitting from Combination Therapy of Transarterial Chemoembolization and Sorafenib for First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Observational Study
Zhexuan Wang, Enxin Wang, Wei Bai, et al.
Liver Cancer
|
August 18, 2022
Lenvatinib with or without Concurrent Drug-Eluting Beads Transarterial Chemoembolization in Patients with Unresectable, Advanced Hepatocellular Carcinoma: A Real-World, Multicenter, Retrospective Study
Dongdong Xia, Wei Bai, Enxin Wang, et al.
European Radiology
|
April 6, 2022
Optimal time point of response assessment for predicting survival is associated with tumor burden in hepatocellular carcinoma receiving repeated transarterial chemoembolization
Dongdong Xia, Qiuhe Wang, Wei Bai, et al.
Journal of Hepatology
|
January 21, 2019
Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational study
Qiuhe Wang, Dongdong Xia, Wei Bai, et al.
JHEP Reports : Innovation in Hepatology
|
January 6, 2025
Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study<sup>☆</sup>
Dongdong Xia, Wei Bai, Qiuhe Wang, et al.
Page
of 2